miércoles, 31 de julio de 2019

A richly funded CRISPR alternative has a reproducibility problem - STAT

A richly funded CRISPR alternative has a reproducibility problem - STAT

Go West

STAT Plus: A richly funded CRISPR alternative has a reproducibility problem

By DAMIAN GARDE


ADOBE
Researchers have cast doubt on the claims upon which Homology Medicines is built.

No hay comentarios: